NationalStockNumber.INFO
Worldwide distributor of NSN parts and consumables located in the USA.
Worldwide distributor of NSN parts and consumables located in the USA.
Send us a request for quote using the form below. Our team will contact you with an up to date pricing and availability quote ASAP.
Medicaments primarily affecting the central nervous system, put up in measured doses or in forms or packings for retail sale, nesoi
Medicaments, n.E.S., in dosage form or retail packings
Pharmaceutical preparations
Y - Indicates information is in the hazardous materials information resource system (hmirs).
PMICA - Item does not contain precious metal.
CRITL- The item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
058770 - Drugs/medicines/vitamins noi
532 - Drugs and medicines excluding pencillin, sulfa, serums, vaccines, and vitamins (not requiring temperature control)
9 - Other or no special handling required (sh)
A - Shipment is not a consolidation and does not exceed 84 inches in any dimension.
M - Medical supplies, equipment, samples, records, etc.
Q - Subject to damage from freezing
W - Rating variable
Questions & Answers: |
|
| What are the historical prices recorded for this stock number? | |
| Historical data shows pricing from $16.44 to $27.41.. | |
| Does NSN 6505-00-079-7867 have a shelf life? | |
| No. There is no shelf life applicable for this NSN. | |
| What NATO entities are users of this NSN? | |
| Kuwait, and Republic Of Korea | |
| What is the NIIN of NSN 6505-00-079-7867? | |
| 000797867 or 00-079-7867 | |
| Does NSN 6505-00-079-7867 require demilitarization? | |
| Yes - ITAR Controlled | |
| What is the most recent solicitation for NSN 6505-00-079-7867? | |
| No solicitations for this NSN. | |
| When was this national stock number assigned to the federal catalog? | |
| Feb 27, 1972 | |
Ld50 lc50 mixture: ld50: 640 mg/kg subcutaneous rat
routes of entry: inhalation: yes skin: yes ingestion: yes
reports of carcinogenicity: ntp: no iarc: no osha: no
health hazards acute and chronic: eye, skin and respiratory irritation
may occur. Note: this product intended for therapeutic use only
when prescribed by a physician.
explanation of carcinogenicity: this compound contains no ingredients at
concentrations of 0.1% or greater that are carcinogens or suspect
carcinogens.
effects of overexposure: eye irritation, skin irritation, respiratory
irritation.
medical cond aggravated by exposure: pre-exisitng skin and respiratory
conditions may be adversely affected by exposure.
First aid: inhalation: move person to fresh air immediately. Give
artificial respiration and cpr if required. Seek medical attention.
ingestion: flush mouth with water immediately. Seek medical
attention. Skin: remove contaminated clothing immediately. Flush
area with water. Seek medical attention. Eyes: immediately flush
with water for at least 15 minutes. Seek medical attention.
Hcc: n1
boiling pt: b.P. Text: not given
melt/freeze pt: m.P/f.P text: not given
vapor pres: not given
vapor density: not given
spec gravity: not given
ph: 3-4.5
evaporation rate & reference: not given
solubility in water: soluble
appearance and odor: clear, colorless, odorless solution
Stability indicator/materials to avoid: yes
none specified by manufacturer.
stability condition to avoid: avoid exposure to light
hazardous decomposition products: smoke, toxic fumes of hcl and nox.
Waste disposal methods: prevent waste from contaminating surrounding
environment. Discard any product, residue, disposal container or
liner in accordance with all federal, state and local regulations.
disclaimer (provided with this information by the compiling agencies):
this information is formulated for use by elements of the department
of defense. the united states of america in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
Ingred name: naloxone hydrochloride
cas: 357-08-4
other rec limits: none recommended
ingred name: methyl paraben 1.8 mg/ml
cas: 99-76-3
other rec limits: none recommended
ingred name: propylparaben (propyl 4-hydroxybenzoate) 0.2 mg/ml
cas: 94-13-3
rtecs #: dh2800000
other rec limits: none recommended
ingred name: sodium chloride 8.6 mg/ml
cas: 7647-14-5
rtecs #: vz4725000
other rec limits: none recommended
ingred name: water
cas: 7732-18-5
rtecs #: zc0110000
other rec limits: none recommended
Ld50 lc50 mixture: ld50 (oral rat) is 1200 mg/kg(free base)
routes of entry: inhalation: no skin: no ingestion: no
reports of carcinogenicity: ntp: no iarc: no osha: no
health hazards acute and chronic: since product is formulated for human
therapeutic use and contains < 1% active ingredient by volume,
normal handling is not expected to constitute a hazard.
explanation of carcinogenicity: this compound contains no ingredients at
concentrations of 0.1% or greater that are carcinogens or suspect
carcinogens.
effects of overexposure: clinical experience with product has found that
in the absence of narcotics, product exhibits essentiially no
pharmacologic activity.
medical cond aggravated by exposure: none specified by manufacturer.
First aid: inhalation: remove to fresh air. If not breathing, give
artificial respiration. If breathing is difficult, give oxygen.
call a physician. Skin: wash with soap and water. Wash contaminated
clothing bef ore reuse. Call a physician. Eyes: immediately flush
with plenty of water for 15 minutes. Call a physician. Ingestion:
immediately give 2 glasses of water and induce vomiting. Call
physician.
Hcc: n1
boiling pt: b.P. Text: not given
melt/freeze pt: m.P/f.P text: 351f,177c
vapor pres: not given
vapor density: not given
spec gravity: not given
evaporation rate & reference: not given
solubility in water: soluble
appearance and odor: clear liquid, no odor
Stability indicator/materials to avoid: yes
none specified by manufacturer.
stability condition to avoid: none specified by manufacturer.
hazardous decomposition products: none specified by manufacturer.
Waste disposal methods: disposal in accordance with federal, state, and
local agencies.
disclaimer (provided with this information by the compiling agencies):
this information is formulated for use by elements of the department
of defense. the united states of america in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
Ingred name: naloxone hydrochloride
cas: 357-08-4
rtecs #: qd2275000
fraction by wt: < 1%
ingred name: inactive ingredients
fraction by wt: > 99%
other rec limits: none recommended
ingred name: proprietary blend tsrn 13600-5037p
other rec limits: none recommended
ingred name: sodium silicate
cas: 1344-09-8
other rec limits: none recommended
ingred name: potassium silicate
cas: 1312-76-1
other rec limits: none recommended